The Safety of Besifloxacin Ophthalmic Suspension 0.6 % Used Three Times Daily for 7 Days in the Treatment of Bacterial Conjunctivitis

Ranjan Malhotra; Stacey Ackerman; Lynne S. Gearinger; Timothy W. Morris; Catherine Allaire

首页> 外文期刊>Drugs in R&D >The Safety of Besifloxacin Ophthalmic Suspension 0.6 % Used Three Times Daily for 7 Days in the Treatment of Bacterial Conjunctivitis

【24h】

The Safety of Besifloxacin Ophthalmic Suspension 0.6 % Used Three Times Daily for 7 Days in the Treatment of Bacterial Conjunctivitis

机译：0.6％贝西沙星眼用混悬剂治疗细菌性结膜炎的安全性，每天连续7天，每天使用3次

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Besifloxacin ophthalmic suspension 0.6% (Besivance®; Bausch & Lomb, Rochester, NY, USA) was approved by the FDA in 2009 for the treatment of bacterial conjunctivitis, with a recommended 7-day dosing regimen.

机译：背景技术0.6％的贝西沙星眼用混悬剂（Besivance®；美国纽约州罗彻斯特市博士伦公司）于2009年获得FDA批准，用于细菌性结膜炎的治疗，推荐使用7天的给药方案。

著录项

来源
《Drugs in R&D》 |2013年第4期|243-252|共10页
作者
Ranjan Malhotra; Stacey Ackerman; Lynne S. Gearinger; Timothy W. Morris; Catherine Allaire;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. The Safety of Besifloxacin Ophthalmic Suspension 0.6?% Used Three Times Daily for 7?Days in the Treatment of Bacterial Conjunctivitis [J] . Ranjan Malhotra, Stacey Ackerman, Lynne S. Gearinger, Drugs in R&D . 2013,第4期

机译：贝西沙星滴眼液0.6？％的安全性，每天3次，共7天，用于治疗细菌性结膜炎
2. Besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis in adults and children [J] . DeLeonJ., SilversteinB.E., AllaireC., Clinical drug investigation . 2012,第5期

机译：每日两次给予贝西沙星眼用混悬液0.6％，连续3天，用于治疗成人和儿童细菌性结膜炎
3. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children. [J] . Silverstein BE, Allaire C, Bateman KM, Clinical therapeutics . 2011,第1期

机译：每天两次，连续3天每天两次给予0.6％的贝西沙星眼用混悬液的疗效和耐受性，用于细菌性结膜炎：这是一项针对成人和儿童的多中心，随机，双盲，媒介物对照，平行组研究。
4. PREPARATION AND EVALUATION OF IN SITU FORMING OPHTHALMIC GELS OF CIPROFLOXACIN HYDROCHLORIDE FOR THE TREATMENT OF BACTERIAL KERATITIS AND CONJUNCTIVITIS [C] . Naseem A. Charoo, Kanchan Kohli, Asgar Ali, Proceedings of the 29th Annual Meeting of the Controlled Release Society . 2002

机译：原位形成眼球蛋白盐酸环丙沙星的制备和评价，用于治疗细菌性角膜炎和结膜炎
5. The Safety of Besifloxacin Ophthalmic Suspension 0.6 Used Three Times Daily for 7 Days in the Treatment of Bacterial Conjunctivitis [O] . Ranjan Malhotra, Stacey Ackerman, Lynne S. Gearinger, -1

机译：0.6％贝西沙星眼用混悬剂治疗细菌性结膜炎的安全性每天连续7天每天使用3次
6. The Safety of Besifloxacin Ophthalmic Suspension 0.6 Used Three Times Daily for 7 Days in the Treatment of Bacterial Conjunctivitis [O] . 2013

机译：0.6％贝西沙星眼用混悬剂治疗细菌性结膜炎的安全性，每天连续7天每天使用3次
7. Daunomycin (NSC-82151). Preclinical Toxicological Evaluation of Single Daily I.V. Injections in Dogs for 3Days Followed by a 3Day No Treatment Period (15Treatments). [R] . 1972

机译：道诺霉素（NsC-82151）。每日单次I.V.的临床前毒理学评价在3Ds中注射狗，然后进行3Day无治疗期（15次治疗）。

The Safety of Besifloxacin Ophthalmic Suspension 0.6 % Used Three Times Daily for 7 Days in the Treatment of Bacterial Conjunctivitis

摘要

著录项

相似文献

相关主题

期刊订阅